Haleon Pakistan Limited (PSX:HALEON)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
744.95
-4.45 (-0.59%)
At close: Apr 30, 2025
192.71%
Market Cap 87.20B
Revenue (ttm) 37.21B
Net Income (ttm) 4.58B
Shares Out 117.05M
EPS (ttm) 39.11
PE Ratio 19.05
Forward PE n/a
Dividend 20.00 (2.67%)
Ex-Dividend Date Mar 11, 2025
Volume 29,041
Average Volume 138,145
Open 740.00
Previous Close 749.40
Day's Range 724.88 - 753.90
52-Week Range 235.00 - 975.00
Beta 0.52
RSI 37.09
Earnings Date Apr 25, 2025

About Haleon Pakistan

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, Africa, Australia, North America, Asia, the Middle East, and Europe. The company offers oral health, pain relief, vitamins and mineral supplements, and respiratory health products. It sells its products under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands. The company also exports its products to the Philippines, Vietnam, and East West Africa region. The company was... [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 450
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HALEON
Full Company Profile

Financial Performance

In 2024, Haleon Pakistan's revenue was 37.21 billion, an increase of 17.70% compared to the previous year's 31.61 billion. Earnings were 4.58 billion, an increase of 359.85%.

Financial Statements

News

There is no news available yet.